Park Medi World Limited (PARKHOSPS)

Healthcare · Healthcare Services · NSE · Updated 4 August 2026

By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings

₹283.95

🎯 Key Takeaways

Park Medi World Limited is in a high-growth expansion phase within the healthcare services sector, driven by aggressive bed capacity additions and strategic acquisitions across North India. Management is executing a disciplined, capital-efficient growth model focused on scaling bed infrastructure and regional density to capture premium case volumes.
⚠️ Occupancy pressure remains a concern, declining to 55.6% from 67.8% YoY, which could weigh on revenue per bed and margin sustainability if not address

Market Cap

₹10,559

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About PARKHOSPS 📊 Interactive Charts

📖 The Story

Park Medi World Limited is in a high-growth expansion phase within the healthcare services sector, driven by aggressive bed capacity additions and strategic acquisitions across North India. Management is executing a disciplined, capital-efficient growth model focused on scaling bed infrastructure and regional density to capture premium case volumes. The company has demonstrated consistent top-line and bottom-line growth, supported by operational expansion and integration of newly acquired facilities.

📰 What's Happening

In Q1 FY'27, the company reported a 19% YoY revenue increase to ₹4,757 crores, fueled by 32% bed capacity growth to 3,960 beds and the addition of 1,490 beds in calendar 2026 through new hospitals in Panchkula, Rudrapur, and Zirakpur. Management highlighted the acquisition of The Medicity Hospital in Rudrapur (330 beds) for INR 177 crores and a 150-bed facility in Zirakpur for INR 107 crores, both part of a broader strategy to reach 5,740 beds by FY'28. The investor presentation emphasized integration of new facilities, operational ramp-up, and funding via internal accruals and IPO proceeds without fresh debt. Shareholders are set to vote on reallocating INR 648.32 million of unutilized IPO funds to finance The Medicity Hospital acquisition, underscoring a strategic shift toward accelerating growth through targeted M&A.

Source: Stock Announcements

🔮 Management Outlook & What's Next

Management has provided a clear roadmap for expansion, targeting 4,740 beds by FY'27 end and 5,740 beds by March 2028, with new facilities to be commissioned through December 2026, including the Palam Vihar expansion in November 2026. They emphasized that growth will be funded without fresh debt, relying instead on internal accruals and previously raised capital. The reallocation of unutilized IPO funds for hospital acquisitions reflects a shift toward deploying capital into high-return, strategic assets to accelerate network density and regional synergies across North India.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Healthcare Services

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
Apollo Hospitals Enterprise Limited	1.16 L Cr	64.5	20.5%	21.9%	0.64
Max Healthcare Institute Limited	1.02 L Cr	101.2	—	—	—
Fortis Healthcare Limited	72,752	94.6	—	—	—
Aster DM Healthcare Limited	39,048	7.1	—	—	—
Narayana Hrudayalaya Ltd.	37,625	47.7	—	—	—
Global Health Limited	33,405	65.8	—	—	—
Krishna Institute of Medical Sciences Limited	30,477	80.3	—	—	—
Dr. Lal Path Labs Ltd.	26,871	63.6	—	—	—
Syngene International Limited	18,295	36.3	—	—	—
Dr. Agarwal's Health Care Limited	14,266	88.8	14.9%	6.8%	0.13

🔗 Peer Stock Analyses

APOLLOHOSP MAXHEALTH FORTIS ASTERDM NH

⚠️ Risk Factors

1. Occupancy pressure remains a concern, declining to 55.6% from 67.8% YoY, which could weigh on revenue per bed and margin sustainability if not addressed through demand generation or pricing power. 2. Integration risks associated with rapid bed capacity additions and acquisitions, particularly in new regions like Rudrapur and Zirakpur, may strain operational execution and patient acquisition. 3. The company's growth strategy is heavily reliant on continued successful integration of new facilities and expansion into new markets, which could be impacted by regulatory, competitive, or execution challenges.

📋 Recent Filings

🧠 Analyst's Read

Park Medi World is executing a capital-efficient expansion strategy with strong financial momentum, but near-term investor focus will be on converting new bed capacity into sustained occupancy and revenue growth. The key watchpoint is execution discipline around operational ramp-up and integration of recent acquisitions, which will determine whether margin expansion and profitability gains can be sustained over the next 12–18 months.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on PARKHOSPS

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-08-04.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PARKHOSPS files new disclosures

Track PARKHOSPS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track PARKHOSPS — Free

Free account · 2 AI queries/day